The debt of IMMUNOVANT, INC. over the past 8 years
Chart IMMUNOVANT, INC.: liquid cash, total debt, net cash, fiscal 2019–2026 Open the chart →At the end of fiscal 2026, the latest fiscal year on file, IMMUNOVANT, INC. had liquid cash of $902.11M and total debt of $0: net cash of $902.11M. It had more liquid cash than debt at all 8 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2026ended Mar 31, 2026 | $902.11M | $0 | $902.11M |
| 2025ended Mar 31, 2025 | $713.97M | $0 | $713.97M |
| 2024ended Mar 31, 2024 | $635.37M | $0 | $635.37M |
| 2023ended Mar 31, 2023 | $376.53M | $0 | $376.53M |
| 2022ended Mar 31, 2022 | $493.82M | $0 | $493.82M |
| 2021ended Mar 31, 2021 | $400.15M | $0 | $400.15M |
| 2020ended Mar 31, 2020 | $100.57M | $0 | $100.57M |
| 2019ended Mar 31, 2019 | $6.99M | $0 | $6.99M |
Fiscal years as IMMUNOVANT, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IMMUNOVANT, INC.
- The profitability of IMMUNOVANT, INC.
- The cash flow of IMMUNOVANT, INC.
- All of IMMUNOVANT, INC.'s financials, charted
Companies of a similar size
- CVICVR ENERGY, INC
- EPRTEssential Properties Realty Trust, Inc.
- CACCCREDIT ACCEPTANCE CORP
- MKTXMARKETAXESS HOLDINGS INC
- TEXTerex Corporation
Not investment advice. This page shows what IMMUNOVANT, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.